@article{article, title = {{1052 Cost-effectiveness of epoetin alfa (EPO) and darbepoetin alfa (DARB) based on hematopoietic response rates and cost of therapy}}, publisher = {{Elsevier BV}}, url = {{}}, year = {{2003}}, month = {{9}}, author = {{Van Hout B and Gagnon D and Guastalla J-P}}, doi = {{10.1016/s1359-6349(03)91078-0}}, volume = {{1}}, journal = {{European Journal of Cancer Supplements}}, issue = {{5}}, pages = {{S313-S314}}, note = {{Accessed on 2025/04/10}}}